These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 1717344

  • 1. The carboxy-terminal catalytic domain of the GTPase-activating protein inhibits nuclear signal transduction and morphological transformation mediated by the CSF-1 receptor.
    Bortner DM, Ulivi M, Roussel MF, Ostrowski MC.
    Genes Dev; 1991 Oct; 5(10):1777-85. PubMed ID: 1717344
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling.
    Colman MS, Ostrowski MC.
    Nucleic Acids Res; 1996 May 15; 24(10):1971-8. PubMed ID: 8657582
    [Abstract] [Full Text] [Related]

  • 5. Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase.
    Ling L, Kung HJ.
    Mol Cell Biol; 1995 Dec 15; 15(12):6582-92. PubMed ID: 8524223
    [Abstract] [Full Text] [Related]

  • 6. A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling.
    Cross M, Csar XF, Wilson NJ, Manes G, Addona TA, Marks DC, Whitty GA, Ashman K, Hamilton JA.
    Biochem J; 2004 May 15; 380(Pt 1):243-53. PubMed ID: 14969583
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain.
    Mattingly RR, Sorisky A, Brann MR, Macara IG.
    Mol Cell Biol; 1994 Dec 15; 14(12):7943-52. PubMed ID: 7969134
    [Abstract] [Full Text] [Related]

  • 9. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
    Rossner MT, McArthur GA, Allen JD, Metcalf D.
    Cell Growth Differ; 1994 May 15; 5(5):549-55. PubMed ID: 8049161
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
    Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ.
    Nature; 1994 May 15; 325(6104):549-52. PubMed ID: 3027579
    [Abstract] [Full Text] [Related]

  • 17. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF.
    Mol Reprod Dev; 1997 Jan 15; 46(1):11-8. PubMed ID: 8981358
    [Abstract] [Full Text] [Related]

  • 18. Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3.
    Corre I, Baumann H, Hermouet S.
    Oncogene; 1999 Nov 04; 18(46):6335-42. PubMed ID: 10597233
    [Abstract] [Full Text] [Related]

  • 19. The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand.
    Rettenmier CW, Roussel MF, Sherr CJ.
    J Cell Sci Suppl; 1988 Nov 04; 9():27-44. PubMed ID: 2978516
    [Abstract] [Full Text] [Related]

  • 20. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
    Nur-E-Kamal MS, Varga M, Maruta H.
    J Biol Chem; 1993 Oct 25; 268(30):22331-7. PubMed ID: 8226742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.